| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.9 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |